Soleno Therapeutics Investors Face Deadline for Significant Loss Claims

Kirby McInerney LLP reminds shareholders of upcoming deadline to file claims related to losses.

Apr. 2, 2026 at 1:37am

Got story updates? Submit your updates here. ›

Kirby McInerney LLP has issued a reminder to investors of Soleno Therapeutics, Inc. that they have until May 5, 2026 to file claims related to significant losses incurred from investing in the company. The law firm is representing shareholders who may have experienced substantial financial losses due to issues with the company.

Why it matters

Soleno Therapeutics is a biopharmaceutical company focused on developing treatments for rare diseases. The upcoming deadline for filing claims suggests there may have been issues with the company's operations or disclosures that led to significant investor losses, which could have broader implications for the pharmaceutical industry and regulatory oversight.

The details

The notice from Kirby McInerney LLP does not provide specifics on the nature of the issues or losses experienced by Soleno Therapeutics investors. However, the law firm is encouraging any shareholders who have incurred substantial losses to come forward and file claims by the May 5th deadline in order to potentially recover damages.

  • The deadline to file claims is May 5, 2026.

The players

Kirby McInerney LLP

A law firm representing Soleno Therapeutics shareholders who have experienced significant losses.

Soleno Therapeutics, Inc.

A biopharmaceutical company focused on developing treatments for rare diseases.

Got photos? Submit your photos here. ›

What’s next

Investors with substantial losses from Soleno Therapeutics must file their claims with Kirby McInerney LLP by the May 5, 2026 deadline in order to potentially recover damages.

The takeaway

This case highlights the importance of transparency and accountability for publicly traded pharmaceutical companies, as significant investor losses can have wide-ranging implications for the industry and regulatory environment.